Catasys (NASDAQ:CATS) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued on Thursday.
According to Zacks, “Catasys, Inc., formerly known as Hythiam, Inc., provides specialized behavioral health management services to health plans, employers and unions through a network of licensed and company managed health care providers. The Company’s program seeks to improve member health by delivering medical and psychosocial interventions in combination with long term care coaching, including their proprietary treatment program for alcoholism and stimulant dependence. Catasys, Inc. is based in Los Angeles. “
A number of other brokerages also recently weighed in on CATS. Taglich Brothers assumed coverage on Catasys in a report on Wednesday, October 18th. They issued a “speculative buy” rating and a $8.00 target price for the company. Telsey Advisory Group assumed coverage on Catasys in a report on Wednesday, October 18th. They issued a “buy” rating for the company. Finally, ValuEngine downgraded Catasys from a “hold” rating to a “sell” rating in a report on Saturday, October 21st.
Catasys (NASDAQ:CATS) last issued its earnings results on Tuesday, November 14th. The company reported ($0.19) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.15) by ($0.04). sell-side analysts anticipate that Catasys will post -0.89 EPS for the current fiscal year.
WARNING: This piece of content was reported by American Banking News and is owned by of American Banking News. If you are reading this piece of content on another website, it was stolen and reposted in violation of United States and international copyright & trademark laws. The correct version of this piece of content can be read at https://www.americanbankingnews.com/2018/02/11/catasys-cats-upgraded-to-hold-at-zacks-investment-research.html.
Catasys Company Profile
Catasys, Inc provides data analytics based specialized behavioral health management and integrated treatment services to health plans and other third party payors. It offers OnTrak solution to improve treatment outcomes and lower the utilization of medical and behavioral health plan services. The companys OnTrak solution includes medical and psychosocial interventions; and a proprietary Web based clinical information platform and database, psychosocial programs, and integrated care coaching services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Catasys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catasys and related companies with MarketBeat.com's FREE daily email newsletter.